1. Region I IPP Infrastructure Updates Advisory Board Meeting November 12, 2009 Boston, MA

2. Data Overview Positivity Progress towards Regional Goals and Objectives

4. Chlamydia Positivity in Region I Family Planning Females by Year % Positive

5. Chlamydia Positivity in Region I Family Planning Females by Year % Positive

6. Regional Goals and Objectives Objective 1.1 By 2010, increase CT screening by 10% of sexually active 15-24 year old women and men. Using 2004 data as the baseline, increase from 38,718 to 42,590 in IPP sites.

7. Objective 1.1

9. Regional Goals and Objectives Objective 2.2 By 2010, no more than 5% of women more than 25 years of age with no risk factors will be screened in IPP- funded clinics (i.e., 95% will be screened according to regional screening criteria).

10. Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

11. Provider Assessment Highlights Screening behavior Knowledge of CDC screening criteria Significance State Specific Results Next Steps

12. Provider Assessment

25. . No screening criteria for males., or symptoms.

26. Provider Assessment

29. criteria for males. or symptoms.

30. Provider Assessment

35. Maps OVERVIEW BULLET POINTS HERE

36. Maps

46. Questions?

47. Other Activities Cost Analysis Definitions/Glossary PTO IHS

48. Connecticut Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

49. Maine Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

50. Massachusetts Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

51. New Hampshire Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

52. Rhode Island Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

53. Vermont Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened)

54. Infrastructure Performance Measures Performance Measure 1 –Screening Coverage Estimate Numerator: Number of women screened Denominator: Number of women eligible to be screened

55. Infrastructure Performance Measures Estimated Screening Coverage by Age Category 2005-2009

56. Infrastructure Performance Measures –Increased screening in the 15-19 and 20-24 age categories over the past 2 years 15-19 screening rose from 35.6% in 2005 to 45.8% in 2007 20-24 screening rose from 34.4% in 2005 to 47.4% in 2007 –Decreased screening in females over 24 over the past 2 years Screening >24 went from 40.5% in 2005 to 37.7% in 2007 –Goals Increase the number of women age 24 and under by at least 3% Decrease the number of women age 24+ by at least 3%

57. Infrastructure Performance Measures Performance Measure 2 –Chlamydia Screening Test Utilization Proportion of total tests given by age category –Numerator: Number of women tested by age category –Denominator: Total number of women tested

58. Infrastructure Performance Measures Proportion of female Tests Utilized, 2005-2009

59. Infrastructure Performance Measures Overview –Very little change over the past 3 years for all 4 age categories Could be a result of budget cuts –Proportion of tests done on women age 29+ is high Could be because data is not broken down by those with and without risk factors, CDC recommends testing age 25+ with risk factors Goal: Increase the proportion of tests utilized by women between the ages of 15-24 from 0.32 to 0.35 –Decrease the proportion of tests utilized by women 29+ from 0.25 to 0.22